keyword
MENU ▼
Read by QxMD icon Read
search

statins with time of dosing

keyword
https://read.qxmd.com/read/30745071/cardioprotective-strategies-to-prevent-breast-cancer-therapy-induced-cardiotoxicity
#1
REVIEW
Allison Padegimas, Suparna Clasen, Bonnie Ky
Breast cancer is the most common malignancy affecting females, with over 260,000 new cases annually and over 3.1 million survivors in the United States alone. Exposure to potentially cardiotoxic therapies, including anthracyclines, trastuzumab, and radiation therapy, coupled with host factors, place patients at increased risk for the development of cardiovascular disease (CVD) compared to non-cancer controls. Overall survival outcomes are significantly worse in patients who develop CVD, and in certain breast cancer populations, cardiovascular death exceeds the risk of cancer death in the long-term...
January 29, 2019: Trends in Cardiovascular Medicine
https://read.qxmd.com/read/30710987/adherence-to-medical-treatment-in-patients-who-have-experienced-acute-coronary-syndrome-and-percutaneous-coronary-intervention
#2
N M Kuzmina, N I Maximov
PURPOSE: to study adherence to therapy after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). We analyzed retrospectively 127 case histories of patients who underwent PCI for ACS in 2015 (in Udmurtia at that time PCIs were mostly carried out later than 6 hours after onset of symptoms). INCLUSION CRITERIA: age 25-75 years; confirmed ACS; stenting of coronary arteries for the first time. EXCLUSION CRITERIA: pregnancy; prisoners; incompetent persons; history of PCI or coronary artery bypass grafting...
January 27, 2019: Kardiologiia
https://read.qxmd.com/read/30701736/the-periprocedural-myocardial-damage-prevention-during-elective-percutaneous-coronary-intervention-as-a-result-of-pharmacological-preconditioning-with-an-oral-form-of-nicorandil-in-patients-with-stable-coronary-artery-disease-pilot-study
#3
R V Gostishchev, G N Soboleva, A N Samko, A N Rogoza, A A Minasyan
AIM: The purpose of the study is to prove the effectiveness of pharmacological preconditioning caused by nicorandil in patients with stable coronary heart disease (CHD) during the elective percutaneous coronary intervention (PCI). MATERIALS AND METHODS: We included 88 patients with a stable form of CHD, who were going to pass the elective PCI, in the study. As the method of blind randomization envelope method was used. There were formed two groups or patients: the first group involved 45 patients - were treated with nicorandil (Cordinic, PIQ-FHARMA LLC) (the main group) the other group included 43 patients who were treated by the standard therapy (the comparison group)...
September 20, 2018: Terapevticheskiĭ Arkhiv
https://read.qxmd.com/read/30676072/moving-targets
#4
Lars E Larsen, Robert M Stoekenbroek, John J P Kastelein, Adriaan G Holleboom
Statin therapy has delivered tremendous value to society by improving the burden of atherosclerotic cardiovascular disease. Nonetheless, atherosclerotic cardiovascular disease remains the leading cause of death globally. Technological advances such as in the field of genomics have revolutionized drug discovery and development and have revealed novel therapeutic targets to lower low-density lipoprotein cholesterol (LDL-C), as well as other detrimental lipids and lipoproteins. Therapeutic LDL-C lowering prevents atherosclerotic cardiovascular disease with an effect size proportional to absolute LDL-C reductions and time of exposure...
January 24, 2019: Arteriosclerosis, Thrombosis, and Vascular Biology
https://read.qxmd.com/read/30652328/prostate-cancer-survival-among-statin-users-after-prostatectomy-in-a-finnish-nationwide-cohort
#5
Roni M Joentausta, Antti Rannikko, Teemu J Murtola
BACKGROUND: Improved prostate cancer (PCa) survival by statin use has been reported among PCa patients managed with radiation or androgen deprivation therapy (ADT), while results are controversial for men managed surgically. We evaluate the association between cholesterol-lowering medication with initiation of ADT and disease-specific death among PCa cases who underwent radical prostatectomy in Finland between 1995 and 2013. METHODS: The study cohort included 14 424 men with PCa who underwent radical prostatectomy in Finland between 1995 and 2013...
January 16, 2019: Prostate
https://read.qxmd.com/read/30625400/statin-use-after-diagnosis-of-hepatocellular-carcinoma-and-patient-survival-findings-from-a-retrospective-cohort-study
#6
Aaron P Thrift, Yamini Natarajan, Yan Liu, Hashem B El-Serag
BACKGROUND & AIMS: Statin use is associated with lower risk of developing hepatocellular carcinoma (HCC). However, it is unclear whether post-diagnosis statin use is associated with reduced risk of mortality in HCC patients. METHODS: We used data from 15,422 patients with HCC in the VA Central Cancer Registry diagnosed between 2002 and 2016. We identified statin prescriptions that were filled before and after cancer diagnosis, and used time-dependent Cox regression models to calculate adjusted hazard ratios (HR) and 95% CIs for mortality risk...
January 5, 2019: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/30621002/evaluation-of-prescription-adaptation-following-changes-to-a-provincial-drug-insurance-formulary
#7
Robert T Pammett
On 1 December 2016, British Columbia's (BC) provincial drug insurance program changed which medications in certain classes would benefit under the insurance program in an attempt to reduce expenditure. As part of the modernization, HMG-CoA reductase inhibitors (Statins), Angiotensin converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and dihydropyridine calcium channel blockers (CCB) were affected. Prescribers and pharmacists had six months to discuss the changes with patients, and change medications if deemed necessary...
January 7, 2019: Pharmacy (Basel, Switzerland)
https://read.qxmd.com/read/30579354/simvastatin-but-not-pravastatin-inhibits-the-proliferation-of-esophageal-adenocarcinoma-and-squamous-cell-carcinoma-cells-a-cell-molecular-study
#8
Yan Chen, Li-Bin Li, Jun Zhang, Du-Peng Tang, Jing-Jing Wei, Ze-Hao Zhuang
BACKGROUND AND OBJECTIVE: Long-term statin therapy has been shown to protect against several cancers, including esophageal cancer (EC). While the mechanisms underlying this effect are not clear. We investigated the effect of hydrophobic simvastatin and hydrophilic pravastatin on the proliferation of EC cells and sought to explore the underlying mechanisms. METHODS: Esophageal adenocarcinoma OE-19 cells and esophageal squamous cell carcinoma Eca-109 cells were treated with different concentrations of simvastatin or pravastatin for 24 h and 48 h...
December 22, 2018: Lipids in Health and Disease
https://read.qxmd.com/read/30552406/effects-of-sartans-and-low-dose-statins-on-cerebral-white-matter-hyperintensities-and-cognitive-function-in-older-patients-with-hypertension-a-randomized-double-blind-and-placebo-controlled-clinical-trial
#9
Hua Zhang, Yi Cui, Yingxin Zhao, Yuanli Dong, Dandan Duan, Juan Wang, Lin Sheng, Tiantian Ji, Tingting Zhou, Wenjing Hu, Yali Chen, Shangwen Sun, Gary Gong, Qiang Chai, Zhendong Liu
Cerebral white matter hyperintensities (WMHs) and cognitive impairment are common in elderly hypertensive patients, and more needs to be learned about their prevention and treatment. Our aim was to investigate the effect of low-dose statins on WMH and cognitive function in elderly patients undergoing antihypertensive treatment. A total of 732 elderly hypertensive patients taking hydrochlorothiazide as their baseline medication were randomized using a 2 × 2 factorial design with antihypertensive (telmisartan vs...
December 14, 2018: Hypertension Research: Official Journal of the Japanese Society of Hypertension
https://read.qxmd.com/read/30541682/determinants-of-inertia-with-lipid-lowering-treatment-in-patients-with-type-2-diabetes-mellitus
#10
Eduardo García Díaz, Davinia Ramírez Medina, Óscar Mauricio Morera Porras, José Luis Cabrera Mateos
OBJECTIVE: To assess the control of cLDL in diabetic patients, to measure the impact on such control of inertia with lipid-lowering agents and to explore factors that allow for predicting this inertia. METHODS: Study of historical cohorts of diabetic patients. The proportion of patients who achieved the target cLDL levels was estimated. Therapeutic inertia was considered when the dose of the lipid-lowering agents was not adjusted, or a lipid-lowering agent was not changed or added in patients with initial cLDL outside the target...
December 9, 2018: Endocrinología, Diabetes y Nutrición
https://read.qxmd.com/read/30529830/trends-in-statin-prescription-prevalence-initiation-and-dosing-hong-kong-2004-2015
#11
Joseph E Blais, Esther W Chan, Sharon W Y Law, Michael T Mok, Duo Huang, Ian C K Wong, Chung-Wah Siu
BACKGROUND AND AIMS: Clinical practice guidelines recommend specific statin doses for the primary and secondary prevention of cardiovascular disease. Little is known about how statin utilization and dosing have evolved over time in Hong Kong. The aim of this study was to describe trends in statin prevalence, initiation, and dosing from 2004 to 2015. METHODS: Patients receiving public health services, who were prescribed a statin, were included if they received a lipid test at a single center (n = 58,672)...
November 10, 2018: Atherosclerosis
https://read.qxmd.com/read/30527197/statins-associate-with-improved-mortality-among-patients-with-certain-histological-subtypes-of-lung-cancer
#12
Matthew H Ung, Todd A MacKenzie, Tracy L Onega, Christopher I Amos, Chao Cheng
OBJECTIVES: To measure the association between statin exposure and mortality in lung cancer patients belonging to different categories of histological subtype. MATERIALS AND METHODS: A cohort of 19,974 individuals with incident lung cancer between 2007 and 2011 was identified using the SEER-Medicare linked database. Statin exposure both pre- and post-diagnosis was analyzed to identify a possible association with cancer-specific mortality in patients stratified by histological subtype...
December 2018: Lung Cancer: Journal of the International Association for the Study of Lung Cancer
https://read.qxmd.com/read/30524720/effect-of-sirolimus-on-carotid-atherosclerosis-in-kidney-transplant-recipients-data-derived-from-a-prospective-randomized-controlled-trial
#13
Andre L Silva, Daniéliso R Fusco, Hong S Nga, Henrique M Takase, Ariane M Bravin, Mariana M Contti, Mariana F Valiatti, Luis Gustavo M de Andrade
Background: In animal models, the mammalian target of rapamycin inhibitors (mTORIs) may prevent atherogenesis by the regulation of homeostasis of cholesterol and by a reduced inflammatory response. The aim of this study is to compare the carotid intima-media thickness (cIMT) between de novo tacrolimus/mycophenolate and tacrolimus/sirolimus at low doses. The cIMT is considered a surrogate marker of atherosclerosis. Methods: We evaluated cIMT at baseline and at 6 and 12 months after kidney transplantation in a database derived from a previously published trial...
December 2018: Clinical Kidney Journal
https://read.qxmd.com/read/30465300/relative-and-absolute-risk-of-tendon-rupture-with-fluoroquinolone-and-concomitant-fluoroquinolone-corticosteroid-therapy-population-based-nested-case-control-study
#14
Daniel R Morales, Jim Slattery, Alexandra Pacurariu, Luis Pinheiro, Patricia McGettigan, Xavier Kurz
BACKGROUND AND OBJECTIVE: Tendon rupture can result from fluoroquinolone exposure. The objective of this study was to quantify relative and absolute risk and determine how risk is affected by timing of exposure. METHODS: The UK Health Improvement Network primary care database was used to perform a nested case-control study measuring the association between fluoroquinolone exposure and tendon rupture. Adults with tendon rupture were matched on age, sex, general practice and calendar time to four controls selected from a cohort prescribed systemic fluoroquinolone or co-amoxiclav antibiotics...
November 21, 2018: Clinical Drug Investigation
https://read.qxmd.com/read/30456916/statin-use-and-survival-in-patients-with-gastric-cancer-in-two-independent-population-based-cohorts
#15
Andrew D Spence, John Busby, Carmel M Hughes, Brian T Johnston, Helen G Coleman, Chris R Cardwell
PURPOSE: Preclinical studies show statins inhibit pathways involved in gastric cancer progression, with observational studies demonstrating reduced gastric cancer risk in statin users. However, few studies have investigated statin use and survival in gastric cancer. We investigated statin use and survival in two large population-based gastric cancer cohorts. METHODS: Patients diagnosed with gastric cancer from 1998 to 2012 were identified from English and Scottish cancer registries...
November 20, 2018: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/30448774/statin-use-and-reduced-risk-of-biliary-tract-cancers-in-the-uk-clinical-practice-research-datalink
#16
Zhiwei Liu, Rotana Alsaggaf, Katherine A McGlynn, Lesley A Anderson, Huei-Ting Tsai, Bin Zhu, Yue Zhu, Sam M Mbulaiteye, Shahinaz M Gadalla, Jill Koshiol
OBJECTIVE: To evaluate the association between statin use and risk of biliary tract cancers (BTC). DESIGN: This is a nested case-control study conducted in the UK Clinical Practice Research Datalink. We included cases diagnosed with incident primary BTCs, including cancers of the gall bladder, bile duct (ie, both intrahepatic and extrahepatic cholangiocarcinoma), ampulla of Vater and mixed type, between 1990 and 2017. For each case, we selected five controls who did not develop BTCs at the time of case diagnosis, matched by sex, year of birth, calendar time and years of enrolment in the general practice using incidence density sampling...
November 17, 2018: Gut
https://read.qxmd.com/read/30442361/intensity-dependent-benefit-of-statins-in-survival-among-prospective-kidney-transplant-patients
#17
Michael Lawrenz F Co, Arianne Clare Agdamag, Mita Zahra Co, Martin Hertl, Burhan Mohamedali
Statin use in patients listed for in kidney transplant is believed to be beneficial. However, the optimum statin dose for improved survival in this high-risk population is unknown. Our study aimed to determine the impact of prekidney transplant statin dosage on survival postkidney transplant. In this retrospective cohort study, we enrolled patients who underwent kidney transplant from January 2005 to September 2015 at Rush University Medical. Data on the statin use and intensity used before kidney transplant were obtained...
October 18, 2018: American Journal of Cardiology
https://read.qxmd.com/read/30430215/statin-associated-immune-mediated-necrotizing-myopathy-a-retrospective-analysis-of-individual-case-safety-reports-from-vigibase
#18
Dirk Essers, Martina Schäublin, Gerd A Kullak-Ublick, Stefan Weiler
PURPOSE: Statins represent an effective treatment for hyperlipidaemia. Immune-mediated necrotising myopathy (IMNM), a form of statin myopathy, has recently been described, and is characterized by elevated creatine kinase, presence of antibodies against HMG-CoA and no improvement after drug discontinuation, even with immunosuppressive treatment. Information on IMNM is mainly from case reports and small case series. Therefore, all reported cases of IMNM in VigiBase, the WHO global database of individual case safety reports (ICSRs) including the underlying reporting patterns, were analysed to characterize more detailed this adverse drug reaction...
November 15, 2018: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/30388834/immunoliposomes-with-simvastatin-as-a-potential-therapeutic-in-treatment-of-breast-cancer-cells-overexpressing-her2-an-in-vitro-study
#19
Lucyna Matusewicz, Joanna Podkalicka, Aleksander F Sikorski
Lipophilic statins are promising candidates for breast cancer treatment. However, anticancer therapy requires much higher doses of statins than can be delivered orally, and such high doses are known to exert more adverse effects. The main objective of our study was to design a targeted, therapeutic liposomal carrier of simvastatin characterised by high stability and specificity towards breast cancer cells. We chose SKBR3, the cell line that showed the highest sensitivity for simvastatin and liposomal simvastatin treatment...
November 1, 2018: Cancers
https://read.qxmd.com/read/30320560/timing-of-clopidogrel-loading-dose-on-peripheral-blood-endothelial-progenitor-cells-sdf-1%C3%AE-and-neointimal-hyperplasia-in-carotid-stenting
#20
Giuseppe Di Stolfo
BACKGROUND: Carotid stenting stimulates intimal proliferation through platelet and stem cell activation. OBJECTIVE: The aim of this study is to evaluate whether the administration before or after carotid stenting of clopidogrel loading dose may play a role on circulating endothelial progenitor cells, stromal cell-derived factor-1α (SDF-1α) and neointimal hyperplasia. METHODS: We recruited 13 patients (aged 74.52±7.23) with indication of carotid revascularization and in therapy with salicylic acid and statin...
September 29, 2019: Clinical Hemorheology and Microcirculation
keyword
keyword
166601
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"